miR-1303 targets claudin-18 gene to modulate proliferation and invasion of gastric cancer cells

Digestive Diseases and Sciences

Volumn 59, Issue 8, 2014, Pages 1754-1763

  Zhang, Shi Jie ^a   Feng, Jian Fang ^b   Wang, Lei ^a   Guo, Wei ^a   Du, Yu Wen ^a   Ming, Liang ^a   Zhao, Guo Qiang ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Claudin 18; Invasion; miR 1303; Proliferation; Stomach neoplasms

Indexed keywords

CLAUDIN 18; MESSENGER RNA; MICRORNA; MICRORNA 1303; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CANCER CELL; CANCER STAGING; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; DOWN REGULATION; FEMALE; GASTRIC CANCER CELL LINE; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR GROWTH; TUMOR INVASION; TUMOR VOLUME; WESTERN BLOTTING; WOUND HEALING;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CLAUDINS; DOWN-REGULATION; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR TARGETED THERAPY; NEOPLASM INVASIVENESS; STOMACH NEOPLASMS;

EID: 84905592392     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-014-3107-5     Document Type: Article

References (38)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-2917.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66. (Pubitemid 46148091)
3. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol . 2006;12:354-362. (Pubitemid 43329250)
4. Zheng L, Wang L, Ajani J, et al. Molecular basis of gastric cancer development and progression. Gastric Cancer. 2004;7:61-77. (Pubitemid 38899656)
5. Ebert MP, Fei G, Kahmann S, et al. Increased beta-catenin mRNA levels and mutational alterations of the APC and betacatenin gene are present in intestinal-type gastric cancer. Carcinogenesis. 2002;23:87-91. (Pubitemid 34213556)
6. Tamura G, Yin J, Wang S, et al. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst. 2000;92:569-573. (Pubitemid 30212319)
7. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843-854. (Pubitemid 24014542)
8. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell. 1993;75:855-862. (Pubitemid 24014543)
9. Gurtan AM, Sharp PA. The role of miRNAs in regulating gene expression networks. J Mol Biol. 2013;425:3582-3600.
10. Farazi TA, Hoell JI, Morozov P, et al. MicroRNAs in human cancer. Adv Exp Med Biol. 2013;774:1-20.
11. Fabbri M. MicroRNAs and cancer: towards a personalized medicine. Curr Mol Med. 2013;13:751-756.
12. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15-20. (Pubitemid 40094598)
13. Hewitt KJ, Agarwal R, Morin PJ. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer. 2006;6:186.
14. Ouban A, Ahmed AA. Claudins in human cancer: a review. Histol Histopathol. 2010;25:83-90.
15. Turksen K. Claudins and cancer stem cells. Stem Cell Rev. 2011;7:797-798.
16. Iravani O, Tay BW, Chua PJ, et al. Claudins and gastric carcinogenesis. Exp Biol Med. 2013;238:344-349.
17. Németh Z, Szász AM, Tátrai P, et al. Claudin-1, -2, -3, -4, -7, -8, and -10 protein expression in biliary tract cancers. J Histochem Cytochem. 2009;57:113-121.
18. Szász M. Claudins as prognostic factors of breast cancer. Magy Onkol. . 2012;56:209-212.
19. Lechpammer M, Resnick MB, Sabo E, et al. The diagnostic and prognostic utility of claudin expression in renal cell neoplasms. Mod Pathol. 2008;21:1320-1329.
20. Niimi T, Nagashima K, Ward JM, et al. Claudin-18, a novel downstream target gene for the T/EBP/NKX2.1 homeodomain transcription factor, encodes lung- and stomach-specific isoforms through alternative splicing. Mol Cell Biol. 2001;21:7380-7390. (Pubitemid 32958540)
21. Sanada Y, Oue N, Mitani Y, et al. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. J Pathol. 2006;208:633-642.
22. Matsuda Y, Semba S, Ueda J, et al. Gastric and intestinal claudin expression at the invasive front of gastric carcinoma. Cancer Sci. 2007;98:1014-1019. (Pubitemid 46865385)
23. Jang BG, Kim WH. Molecular pathology of gastric carcinoma. Pathobiology. 2011;78:302-310.
24. Oshima T, Shan J, Okugawa T, et al. Down-regulation of claudin-18 is associated with the proliferative and invasive potential of gastric cancer at the invasive front. PLoS ONE. 2013;8:e74757.
25. Ayaz L, Görür A, Yaroǧlu HY, et al. Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detectionmarkers for laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol. 2013;139:1499-1506.
26. El-Murr N, Abidi Z, Wanherdrick K, et al. MiRNA genes constitute new targets for microsatellite instability in colorectal cancer. PLoS ONE. 2012;7:e31862.
27. Maurel M, Jalvy S, Ladeiro Y, et al. A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma. Hepatology. 2013;57:195-204.
28. Xi JJ. MicroRNAs in cancer. Cancer Treat Res. 2013;158:119-137.
29. Li X, Zhang Y, Zhang Y, et al. Survival prediction of gastric cancer by a seven-microRNA signature. Gut. 2010;59:579-585.
30. Yao Y, Suo AL, Li ZF, et al. MicroRNA profiling of human gastric cancer. Mol Med Rep. 2009;2:963-970.
31. Brenner B, Hoshen MB, Purim O, et al. MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol. 2011;17:3976-3985.
32. Yan Z, Xiong Y, Xu W, et al. Identification of recurrence-related genes by integrating microRNA and gene expression profiling of gastric cancer. Int J Oncol. 2012;41:2166-2174.
33. Tong F, Cao P, Yin Y, et al. MicroRNAs in gastric cancer: from benchtop to bedside. Dig Dis Sci. 2014;59:24-30.
34. Sahin U, Koslowski M, Dhaene K, et al. Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development. Clin Cancer Res. 2008;14:7624-7634.
35. Türeci O, Koslowski M, Helftenbein G, et al. Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals. Gene. 2011;481:83-92.
36. Tanaka M, Shibahara J, Fukushima N, et al. Claudin-18 is an early-stage marker of pancreatic carcinogenesis. J Histochem Cytochem. 2011;59:942-952.
37. Lerebours F, Cizeron-Clairac G, Susini A, et al. miRNA expression profiling of inflammatory breast cancer identifies a 5-miRNA signature predictive of breast tumor aggressiveness. Int J Cancer. 2013;133:1614-1623.
38. Hansen TB, Kjems J, Bramsen JB. Enhancing miRNA annotation confidence in miRBase by continuous cross dataset analysis. RNA Biol. 2011;8:378-383.